HIV-AIDS Testing Market 2027 By Product, Test Type, End User | The Insight Partners

HIV-AIDS Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Consumables, Instruments, Software and Services); Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification); End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users)

Report Code: TIPRE00016713 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy.

MARKET DYNAMICS

The HIV-AIDS testing market is driving due to growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide. However, low market penetration in emerging and underdeveloped economies might hamper the market growth in the review period.

MARKET SCOPE

The "HIV-AIDS Testing Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of HIV-AIDS testing market with detailed market segmentation by product, test type, end-user. The HIV-AIDS testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in HIV-AIDS testing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The HIV-AIDS testing market is segmented on the basis of product, test type, end-user. On the basis of product, the market is segmented into consumables, instruments, software and services and others. On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 tests, tests for early infant diagnosis, and tests for viral identification. On the basis of end-user, the market is segmented into diagnostic laboratories, hospitals, blood banks, home care settings, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the HIV-AIDS Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The HIV-AIDS Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting HIV-AIDS Testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the HIV-AIDS Testing market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the HIV-AIDS testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from HIV-AIDS testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for HIV-AIDS testing market in the global market. Below mentioned is the list of few companies engaged in the HIV-AIDS testing market.

The report also includes the profiles of key players in HIV-AIDS testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Alere Inc.
  •  Abbott Healthcare
  •  Abbvie Inc.
  •  Brsitol-Myers Squibb
  •  Janssen Therapeutics
  •  Gilead Sciences
  •  Merck and Co. Inc
  •  VIIV Healthcare
  •  BD Biosciences
  •  Beckman Coulter

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 HIV-AIDS Testing Market - By Product
1.3.2 HIV-AIDS Testing Market - By Test Type
1.3.3 HIV-AIDS Testing Market - By End User
1.3.4 HIV-AIDS Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HIV-AIDS TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HIV-AIDS TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HIV-AIDS TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. HIV-AIDS TESTING - GLOBAL MARKET OVERVIEW
6.2. HIV-AIDS TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HIV-AIDS TESTING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.5. SOFTWARE AND SERVICES
7.5.1. Overview
7.5.2. Software and Services Market Forecast and Analysis
8. HIV-AIDS TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANTIBODY TESTS
8.3.1. Overview
8.3.2. Antibody Tests Market Forecast and Analysis
8.4. VIRAL LOAD TESTS
8.4.1. Overview
8.4.2. Viral Load Tests Market Forecast and Analysis
8.5. CD4 TESTS
8.5.1. Overview
8.5.2. CD4 Tests Market Forecast and Analysis
8.6. TESTS FOR EARLY INFANT DIAGNOSIS
8.6.1. Overview
8.6.2. Tests for Early Infant Diagnosis Market Forecast and Analysis
8.7. TESTS FOR VIRAL IDENTIFICATION
8.7.1. Overview
8.7.2. Tests for Viral Identification Market Forecast and Analysis
9. HIV-AIDS TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC LABORATORIES
9.3.1. Overview
9.3.2. Diagnostic Laboratories Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. BLOOD BANKS
9.5.1. Overview
9.5.2. Blood Banks Market Forecast and Analysis
9.6. HOME CARE SETTINGS
9.6.1. Overview
9.6.2. Home Care Settings Market Forecast and Analysis
9.7. OTHER END USERS
9.7.1. Overview
9.7.2. Other End Users Market Forecast and Analysis
10. HIV-AIDS TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America HIV-AIDS Testing Market Overview
10.1.2 North America HIV-AIDS Testing Market Forecasts and Analysis
10.1.3 North America HIV-AIDS Testing Market Forecasts and Analysis - By Product
10.1.4 North America HIV-AIDS Testing Market Forecasts and Analysis - By Test Type
10.1.5 North America HIV-AIDS Testing Market Forecasts and Analysis - By End User
10.1.6 North America HIV-AIDS Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States HIV-AIDS Testing Market
10.1.6.1.1 United States HIV-AIDS Testing Market by Product
10.1.6.1.2 United States HIV-AIDS Testing Market by Test Type
10.1.6.1.3 United States HIV-AIDS Testing Market by End User
10.1.6.2 Canada HIV-AIDS Testing Market
10.1.6.2.1 Canada HIV-AIDS Testing Market by Product
10.1.6.2.2 Canada HIV-AIDS Testing Market by Test Type
10.1.6.2.3 Canada HIV-AIDS Testing Market by End User
10.1.6.3 Mexico HIV-AIDS Testing Market
10.1.6.3.1 Mexico HIV-AIDS Testing Market by Product
10.1.6.3.2 Mexico HIV-AIDS Testing Market by Test Type
10.1.6.3.3 Mexico HIV-AIDS Testing Market by End User
10.2. EUROPE
10.2.1 Europe HIV-AIDS Testing Market Overview
10.2.2 Europe HIV-AIDS Testing Market Forecasts and Analysis
10.2.3 Europe HIV-AIDS Testing Market Forecasts and Analysis - By Product
10.2.4 Europe HIV-AIDS Testing Market Forecasts and Analysis - By Test Type
10.2.5 Europe HIV-AIDS Testing Market Forecasts and Analysis - By End User
10.2.6 Europe HIV-AIDS Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany HIV-AIDS Testing Market
10.2.6.1.1 Germany HIV-AIDS Testing Market by Product
10.2.6.1.2 Germany HIV-AIDS Testing Market by Test Type
10.2.6.1.3 Germany HIV-AIDS Testing Market by End User
10.2.6.2 France HIV-AIDS Testing Market
10.2.6.2.1 France HIV-AIDS Testing Market by Product
10.2.6.2.2 France HIV-AIDS Testing Market by Test Type
10.2.6.2.3 France HIV-AIDS Testing Market by End User
10.2.6.3 Italy HIV-AIDS Testing Market
10.2.6.3.1 Italy HIV-AIDS Testing Market by Product
10.2.6.3.2 Italy HIV-AIDS Testing Market by Test Type
10.2.6.3.3 Italy HIV-AIDS Testing Market by End User
10.2.6.4 Spain HIV-AIDS Testing Market
10.2.6.4.1 Spain HIV-AIDS Testing Market by Product
10.2.6.4.2 Spain HIV-AIDS Testing Market by Test Type
10.2.6.4.3 Spain HIV-AIDS Testing Market by End User
10.2.6.5 United Kingdom HIV-AIDS Testing Market
10.2.6.5.1 United Kingdom HIV-AIDS Testing Market by Product
10.2.6.5.2 United Kingdom HIV-AIDS Testing Market by Test Type
10.2.6.5.3 United Kingdom HIV-AIDS Testing Market by End User
10.2.6.6 Rest of Europe HIV-AIDS Testing Market
10.2.6.6.1 Rest of Europe HIV-AIDS Testing Market by Product
10.2.6.6.2 Rest of Europe HIV-AIDS Testing Market by Test Type
10.2.6.6.3 Rest of Europe HIV-AIDS Testing Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific HIV-AIDS Testing Market Overview
10.3.2 Asia-Pacific HIV-AIDS Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific HIV-AIDS Testing Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific HIV-AIDS Testing Market Forecasts and Analysis - By Test Type
10.3.5 Asia-Pacific HIV-AIDS Testing Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific HIV-AIDS Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia HIV-AIDS Testing Market
10.3.6.1.1 Australia HIV-AIDS Testing Market by Product
10.3.6.1.2 Australia HIV-AIDS Testing Market by Test Type
10.3.6.1.3 Australia HIV-AIDS Testing Market by End User
10.3.6.2 China HIV-AIDS Testing Market
10.3.6.2.1 China HIV-AIDS Testing Market by Product
10.3.6.2.2 China HIV-AIDS Testing Market by Test Type
10.3.6.2.3 China HIV-AIDS Testing Market by End User
10.3.6.3 India HIV-AIDS Testing Market
10.3.6.3.1 India HIV-AIDS Testing Market by Product
10.3.6.3.2 India HIV-AIDS Testing Market by Test Type
10.3.6.3.3 India HIV-AIDS Testing Market by End User
10.3.6.4 Japan HIV-AIDS Testing Market
10.3.6.4.1 Japan HIV-AIDS Testing Market by Product
10.3.6.4.2 Japan HIV-AIDS Testing Market by Test Type
10.3.6.4.3 Japan HIV-AIDS Testing Market by End User
10.3.6.5 South Korea HIV-AIDS Testing Market
10.3.6.5.1 South Korea HIV-AIDS Testing Market by Product
10.3.6.5.2 South Korea HIV-AIDS Testing Market by Test Type
10.3.6.5.3 South Korea HIV-AIDS Testing Market by End User
10.3.6.6 Rest of Asia-Pacific HIV-AIDS Testing Market
10.3.6.6.1 Rest of Asia-Pacific HIV-AIDS Testing Market by Product
10.3.6.6.2 Rest of Asia-Pacific HIV-AIDS Testing Market by Test Type
10.3.6.6.3 Rest of Asia-Pacific HIV-AIDS Testing Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa HIV-AIDS Testing Market Overview
10.4.2 Middle East and Africa HIV-AIDS Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa HIV-AIDS Testing Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa HIV-AIDS Testing Market Forecasts and Analysis - By Test Type
10.4.5 Middle East and Africa HIV-AIDS Testing Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa HIV-AIDS Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa HIV-AIDS Testing Market
10.4.6.1.1 South Africa HIV-AIDS Testing Market by Product
10.4.6.1.2 South Africa HIV-AIDS Testing Market by Test Type
10.4.6.1.3 South Africa HIV-AIDS Testing Market by End User
10.4.6.2 Saudi Arabia HIV-AIDS Testing Market
10.4.6.2.1 Saudi Arabia HIV-AIDS Testing Market by Product
10.4.6.2.2 Saudi Arabia HIV-AIDS Testing Market by Test Type
10.4.6.2.3 Saudi Arabia HIV-AIDS Testing Market by End User
10.4.6.3 U.A.E HIV-AIDS Testing Market
10.4.6.3.1 U.A.E HIV-AIDS Testing Market by Product
10.4.6.3.2 U.A.E HIV-AIDS Testing Market by Test Type
10.4.6.3.3 U.A.E HIV-AIDS Testing Market by End User
10.4.6.4 Rest of Middle East and Africa HIV-AIDS Testing Market
10.4.6.4.1 Rest of Middle East and Africa HIV-AIDS Testing Market by Product
10.4.6.4.2 Rest of Middle East and Africa HIV-AIDS Testing Market by Test Type
10.4.6.4.3 Rest of Middle East and Africa HIV-AIDS Testing Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America HIV-AIDS Testing Market Overview
10.5.2 South and Central America HIV-AIDS Testing Market Forecasts and Analysis
10.5.3 South and Central America HIV-AIDS Testing Market Forecasts and Analysis - By Product
10.5.4 South and Central America HIV-AIDS Testing Market Forecasts and Analysis - By Test Type
10.5.5 South and Central America HIV-AIDS Testing Market Forecasts and Analysis - By End User
10.5.6 South and Central America HIV-AIDS Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil HIV-AIDS Testing Market
10.5.6.1.1 Brazil HIV-AIDS Testing Market by Product
10.5.6.1.2 Brazil HIV-AIDS Testing Market by Test Type
10.5.6.1.3 Brazil HIV-AIDS Testing Market by End User
10.5.6.2 Argentina HIV-AIDS Testing Market
10.5.6.2.1 Argentina HIV-AIDS Testing Market by Product
10.5.6.2.2 Argentina HIV-AIDS Testing Market by Test Type
10.5.6.2.3 Argentina HIV-AIDS Testing Market by End User
10.5.6.3 Rest of South and Central America HIV-AIDS Testing Market
10.5.6.3.1 Rest of South and Central America HIV-AIDS Testing Market by Product
10.5.6.3.2 Rest of South and Central America HIV-AIDS Testing Market by Test Type
10.5.6.3.3 Rest of South and Central America HIV-AIDS Testing Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HIV-AIDS TESTING MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HIV-AIDS TESTING MARKET, KEY COMPANY PROFILES
13.1. ALERE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT HEALTHCARE
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBVIE INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BRSITOL MYERS SQUIBB
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. JANSSEN THERAPEUTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GILEAD SCIENCES
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO. INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. VIIV HEALTHCARE
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BD BIOSCIENCES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BECKMAN COULTER
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Alere Inc.
2. Abbott Healthcare
3. Abbvie Inc.
4. Brsitol-Myers Squibb
5. Janssen Therapeutics
6. Gilead Sciences
7. Merck and Co. Inc
8. VIIV Healthcare
9. BD Biosciences
10. Beckman Coulter
TIPRE00016713
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking